According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

the single-dose nasal spray is designed to be administered into one nostril, and was approved for use in adults and kids who weigh at least 66 pounds with severe allergies. Related: FDA approves ...

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The US Food and Drug Administration (FDA) has approved the first nasal medicine to treat severe allergies. On 9 August, US health officials approved the first nasal spray to treat allergic ...

Last week the FDA approved Neffy, an epinephrine nasal spray, for use in emergency allergic reactions for kids and adults. Retired allergist at the Northwest Asthma & Allergy Center Paul Williams said ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

U.S. health officials on Friday approved a nasal spray to treat severe ... She said, “we are over the moon” about the FDA’s approval of the spray, which Zacky will start carrying when ...